抗苗勒管激素与不明原因复发性妊娠丢失后的活产
丹麦哥本哈根大学医院2015至2021年纳入629例不明原因复发性妊娠丢失女性,检测转诊时抗苗勒管激素(AMH)并随访下次妊娠活产率。低、中、高AMH组妊娠率及活产率均无显著差异,辅助生殖技术妊娠活产率较低(aOR 0.57)。
要点
- 不明原因复发性妊娠丢失女性中,AMH水平与下次妊娠活产率无显著关联。
- 低AMH组活产率59.5%,中AMH组66.1%,高AMH组65.1%,调整后无显著差异。
- 辅助生殖技术妊娠活产率较低(aOR 0.57,95%CI 0.33-0.97,P=0.04)。
核心结论
- 在不不明原因复发性妊娠丢失女性中,AMH与下次妊娠活产机会无关。
- 当前证据不支持对所有复发性妊娠丢失女性常规筛查AMH。
- 通过辅助生殖技术妊娠的不明原因复发性妊娠丢失女性活产机会较低,需未来研究确认和探索。
研究设计与样本
- 队列研究,纳入2015至2021年丹麦哥本哈根大学医院复发性妊娠丢失门诊的不明原因复发性妊娠丢失女性。
- 共纳入629例女性,转诊时检测AMH浓度,随访下次妊娠的活产率。
- 复发性妊娠丢失定义为连续3次或以上妊娠丢失。
- 回归分析调整了年龄、既往丢失次数、体重指数、吸烟、辅助生殖技术治疗及复发性妊娠丢失治疗。
主要发现
- 507例(80.6%)在转诊后妊娠。
- 低AMH组、中AMH组和高AMH组的妊娠率分别为81.9%、79.7%和80.3%,低AMH组与中AMH组比较aOR 1.44(95%CI 0.84-2.47,P=0.18),高AMH组与中AMH组比较aOR 0.98(95%CI 0.59-1.64,P=0.95)。
- 低AMH组、中AMH组和高AMH组的活产率分别为59.5%、66.1%和65.1%,低AMH组与中AMH组比较aOR 0.68(95%CI 0.41-1.11,P=0.12),高AMH组与中AMH组比较aOR 0.96(95%CI 0.59-1.56,P=0.87)。
- 辅助生殖技术妊娠的活产率较低(aOR 0.57,95%CI 0.33-0.97,P=0.04)。
- 既往丢失次数越多,活产率越低(aOR 0.81,95%CI 0.68-0.95,P=0.01)。
临床怎么用
- 作者结论指出,当前证据不支持对所有复发性妊娠丢失女性筛查AMH。
- 作者指出,通过辅助生殖技术妊娠的不明原因复发性妊娠丢失女性活产机会较低,需未来研究确认和探索。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is anti-Müllerian hormone (AMH) associated with live birth rate (LBR) in women with unexplained recurrent pregnancy loss (RPL)? DESIGN: Cohort study of women with unexplained RPL attending the RPL Unit, Copenhagen University Hospital, Denmark, between 2015 and 2021. AMH concentration was assessed upon referral, and LBR in the next pregnancy. RPL was defined as three or more consecutive pregnancy losses. Regression analyses were adjusted for age, number of previous losses, body mass index, smoking, treatment with assisted reproductive technology (ART) and RPL treatments. RESULTS: A total of 629 women were included; 507 (80.6%) became pregnant after referral. Pregnancy rates were similar for women with low and high AMH compared to women with medium AMH (81.9, 80.3 and 79.7%, respectively) (low AMH: adjusted odds ratio [aOR] 1.44, 95% confidence interval [CI] 0.84-2.47, P = 0.18; high AMH: aOR 0.98, 95% CI 0.59-1.64, P = 0.95). AMH concentrations were not associated with live birth. LBR was 59.5% in women with low AMH, 66.1% with medium AMH and 65.1% with high AMH (low AMH: aOR 0.68, 95% CI 0.41-1.11, P = 0.12, high AMH: aOR 0.96, 95% CI 0.59-1.56, P = 0.87). Live birth was lower in ART pregnancies (aOR 0.57, 95% CI 0.33-0.97, P = 0.04) and with higher numbers of previous losses (aOR 0.81, 95% CI 0.68-0.95, P = 0.01). CONCLUSION: In women with unexplained RPL, AMH was not associated with the chances of live birth in the next pregnancy. Screening for AMH in all women with RPL is not supported by current evidence. The chance of live birth among women with unexplained RPL achieving pregnancy by ART was low and needs to be confirmed and explored in future studies.
引用
- Bliddal S, Feldt-Rasmussen U, Forman JL, et al. Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss. Reprod Biomed Online. 2023. PMID: 37055255. doi:10.1016/j.rbmo.2023.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。